Perioperative goal-directed haemodynamic therapy (GDT) is a protocolised treatment strategy aimed at optimisation of global cardiovascular dynamics, including oxygen delivery to tissues and organ perfusion pressure. This is achieved by titrating fluids, vasopressors, and inotropes to predefined physiological target values of haemodynamic variables.1 First proposed in the 1980s by Shoemaker and colleagues,2 perioperative GDT has been refined, further developed, and widely tested in clinical trials over the past two decades.
No takes yet. Share an insight, caveat, or question.
Saugel et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: